ARL3 Enhances ERα Stability via USP10 Deubiquitination to Promote Endocrine Resistance and Drive Mitochondrial Metabolic Reprogramming in HR+ Breast Cancer.

Saved in:
Bibliographic Details
Title: ARL3 Enhances ERα Stability via USP10 Deubiquitination to Promote Endocrine Resistance and Drive Mitochondrial Metabolic Reprogramming in HR+ Breast Cancer.
Authors: Li, Han1,2 (AUTHOR), Liu, Yang1,2 (AUTHOR), Cai, Zehao1,2 (AUTHOR), Li, Kang1,2 (AUTHOR), Gao, Shun1 (AUTHOR), Lan, Ailin2,3 (AUTHOR), Shu, Dan1 (AUTHOR), He, Kuan1 (AUTHOR), Liu, Xin1 (AUTHOR), Peng, Yang1 (AUTHOR), Guo, Shipeng1 (AUTHOR), Yu, Haochen1 (AUTHOR), Jin, Aishun2,4 (AUTHOR), Shen, Meiying1,2 (AUTHOR) meiying@hospital.cqmu.edu.cn, Liu, Shengchun1 (AUTHOR) 202187@cqmu.edu.cn
Source: Advanced Science. 12/18/2025, Vol. 12 Issue 47, p1-18. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21983844
DOI:10.1002/advs.202509769